MAPK3 and hepatocellular carcinoma: The presence of elevated ROS levels promotes HCC through diverse signaling pathways, including renin–angiotensin system (Ras)/extracellular-regulated kinases 1 and 2 (ERK1/2) signaling pathways (12, 13, 14).